{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:18:04Z","timestamp":1791433084065,"version":"4.3.3"},"reference-count":41,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100017511","name":"Metro North Hospital and Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2007718"],"award-info":[{"award-number":["2007718"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Aust N Z J Psychiatry"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Recent regulatory changes in Australia have approved 3,4-methylenedioxymethamphetamine for treating post-traumatic stress disorder and psilocybin for treatment-resistant depression. However, limited data exists on Australian mental healthcare providers\u2019 attitudes, knowledge and readiness to implement with psychedelic-assisted psychotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cross-sectional survey was conducted between December 2023 and March 2024, targeting Australian general practitioners, psychiatrists and psychologists. Participants completed online questionnaires developed based on the Knowledge, Attitude and Practices framework to explore mental healthcare providers\u2019 knowledge, attitudes and practices toward psychedelics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The survey was completed by 109 clinicians (21% psychiatrists, 56% psychologists, 23% general practitioners). Attitudes toward psychedelic-assisted therapy were positive. However, safety and efficacy concerns persisted, particularly among psychiatrists, who were significantly more likely than psychologists to perceive psychedelic use as unsafe under medical supervision and question the scientific rigor of current research. Self-rated knowledge positively predicted actual knowledge, though many clinicians relied on informal sources such as podcasts and Internet-based media, highlighting gaps in evidence-based education. Clinicians with personal experience of psychedelic use expressed higher levels of agreement with statements relating to psychedelics improving outcomes in conjunction with psychotherapy and showing promise in treating psychiatric disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>While Australian mental healthcare providers generally support psychedelic-assisted psychotherapy, significant safety and efficacy concerns remain, particularly among psychiatrists. Targeted educational initiatives from professional bodies, emphasizing evidence-based training and accessible resources, are essential to support informed clinical decision-making and safe therapeutic practices in this emerging field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00048674251346679","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T07:52:01Z","timestamp":1752565921000},"page":"798-809","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers"],"prefix":"10.1177","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1889-9859","authenticated-orcid":false,"given":"Zohaib","family":"Nadeem","sequence":"first","affiliation":[{"name":"Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6022-3981","authenticated-orcid":false,"given":"Stephen","family":"Parker","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia"},{"name":"Metro North Mental Health, Royal Brisbane and Women\u2019s Hospital, Herston, QLD, Australia"},{"name":"Faculty of Medicine, Griffith University, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"McGovern","sequence":"additional","affiliation":[{"name":"IMPACT \u2013 The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Sebben","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research (QIMR) Berghofer, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4978-7794","authenticated-orcid":false,"given":"Lena KL","family":"Oestreich","sequence":"additional","affiliation":[{"name":"School of Psychology, The University of Queensland, Brisbane, QLD, Australia"},{"name":"Centre for Advanced Imaging (CAI) and Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"Administration (TGA) TG (2023) Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists| Therapeutic Goods Administration (TGA). Therapeutic Goods Administration (TGA). Available at: www.tga.gov.au\/news\/media-releases\/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists (accessed 24 February 2024)."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000828"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2021.1957183"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/10398562231156684"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1224551"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032994"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-021-02668-2"},{"key":"e_1_3_3_9_1","first-page":"89","article-title":"Ecstasy (MDMA): A rebellion coherent with the system","volume":"38","author":"Garc\u00eda-Montes JM","year":"2021","unstructured":"Garc\u00eda-Montes JM, P\u00e9rez-\u00c1lvarez M, S\u00e1nchez-Moya M\u00c1, et al. (2021) Ecstasy (MDMA): A rebellion coherent with the system. Nordisk Alkohol & Narkotikatidskrift: NAT 38: 89\u2013102.","journal-title":"Nordisk Alkohol & Narkotikatidskrift: NAT"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/10398562231155125"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115531"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-023-02093-8"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp-rj.2024.200108"},{"key":"e_1_3_3_15_1","unstructured":"Heidi Anne Duerr MPH (2024) With MDMA on hold What\u2019s next for psychedelics? Psychiatric Times 41(9). Available at: https:\/\/www.psychiatrictimes.com\/view\/with-mdma-on-hold-whats-next-for-psychedelics"},{"key":"e_1_3_3_16_1","unstructured":"IBM SPSS Statistics for Macintosh (2023) IBM Corp. Available at: https:\/\/www.ibm.com\/products\/spss-statistics"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674231174171"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.2880"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.17061\/phrp3332321"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.12.050"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02565-4"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674241261779"},{"key":"e_1_3_3_23_1","unstructured":"National Drug Strategy Household Survey 2022\u20132023 (2024) Australian Institute of Health and Welfare. Available at: www.aihw.gov.au\/reports\/illicit-use-of-drugs\/national-drug-strategy-household-survey\/contents\/about (accessed 6 January 2025)."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13973"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p1599"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118806297"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jts.22696"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.14530"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-024-02597-x"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241309611"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674231172691"},{"key":"e_1_3_3_33_1","unstructured":"RStudio: Integrated Development Environment for R (2023) RStudio PBC. Available at: www.rstudio.com\/ (accessed September 2024)."},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.12.040"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06083-y"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06737-1"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101809"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78736-1"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2023.00294"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230681"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-060360"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69688-7"}],"container-title":["Australian &amp; New Zealand Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00048674251346679","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00048674251346679","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00048674251346679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:58:05Z","timestamp":1777373885000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00048674251346679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1177\/00048674251346679"],"URL":"https:\/\/doi.org\/10.1177\/00048674251346679","relation":{},"ISSN":["0004-8674","1440-1614"],"issn-type":[{"value":"0004-8674","type":"print"},{"value":"1440-1614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]}}}